{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:20:27Z","timestamp":1760833227950,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Muscular Dystrophy Association of Western Australia"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.nmd.2014.10.002","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T16:30:55Z","timestamp":1415723455000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigating sodium valproate as a treatment for McArdle disease in sheep"],"prefix":"10.1016","volume":"25","author":[{"given":"J.McC.","family":"Howell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Dunton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Creed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sewry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2014.10.002_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ana.410030109","article-title":"McArdle disease: the mystery of re-appearing phosphorylase activity in muscle culture \u2013 a fetal isoenzyme","volume":"3","author":"DiMauro","year":"1978","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2014.10.002_bib0015","unstructured":"Walker K.R.. Characterisation of the Ovine Model of McArdle's disease: development of therapeutic strategies [Ph.D. thesis]. Murdoch University, 2006."},{"key":"10.1016\/j.nmd.2014.10.002_bib0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0960-8966(97)00062-X","article-title":"A splice-site mutation causing ovine McArdle's disease","volume":"7","author":"Tan","year":"1997","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.10.002_bib0025","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nmd.2011.07.002","article-title":"Molecular and clinical study of McArdle's disease in a cohort of 123 European patients. Identification of 20 novel mutations","volume":"21","author":"Vieitez","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.10.002_bib0030","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/088307388900400305","article-title":"Fatal infantile phosphorylase deficiency","volume":"4","author":"Milstein","year":"1989","journal-title":"J Child Neurol"},{"key":"10.1016\/j.nmd.2014.10.002_bib0035","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/01677068709167190","article-title":"McArdle's and Hers\u2019 diseases: glycogen phosphorylase transcriptional expression in human tissues","volume":"4","author":"Gorin","year":"1987","journal-title":"J Neurogenet"},{"key":"10.1016\/j.nmd.2014.10.002_bib0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0006-291X(77)90230-3","article-title":"Characterization of glycogen phosphorylase isoenzymes present in cultured skeletal muscle from patients with McArdle's disease","volume":"78","author":"Sato","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2014.10.002_bib0045","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/mus.880180710","article-title":"Myophosphorylase deficiency associated with rhabdomyolysis and exercise intolerance in 6 related Charolais cattle","volume":"18","author":"Angelos","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2014.10.002_bib0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/brain\/aws141","article-title":"Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease","volume":"35","author":"Nogales-Gadea","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2014.10.002_bib0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.nmd.2007.10.006","article-title":"Adenovirus and adeno-associated virus-mediated delivery of human myophosphorylase cDNA and LacZ cDNA to muscle in the ovine model of McArdle's disease: expression and re-expression of glycogen phosphorylase","volume":"18","author":"Howell","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.10.002_bib0060","first-page":"358","article-title":"An increase in strength of contraction accompanies notexin induced re-expression of phosphorylase brain isoform in regenerating ovine McArdle's muscle","author":"Howell","year":"2008","journal-title":"Myology"},{"key":"10.1016\/j.nmd.2014.10.002_bib0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.nmd.2013.10.003","article-title":"Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease","volume":"24","author":"Howell","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2014.10.002_bib0070","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylase: unique players in shaping the epigenetic code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.nmd.2014.10.002_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003458.pub4","article-title":"Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)","author":"Quinlivan","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nmd.2014.10.002_bib0080","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jnnp.2009.195040","article-title":"McArdle disease: a clinical review","volume":"81","author":"Quinlivan","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2014.10.002_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/10409238909082552","article-title":"The family of glycogen phosphorylases: structure and function","volume":"24","author":"Newgard","year":"1989","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.nmd.2014.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0002-9440(10)65447-8","article-title":"McArdle's disease. The unsolved mystery of the reappearing enzyme","volume":"154","author":"Martinuzzi","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nmd.2014.10.002_bib0095","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/brain\/awp065","article-title":"Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease","volume":"132","author":"Vissing","year":"2009","journal-title":"Brain"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614006634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896614006634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:02:56Z","timestamp":1760774576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896614006634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0960896614006634"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2014.10.002","relation":{},"ISSN":["0960-8966"],"issn-type":[{"type":"print","value":"0960-8966"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating sodium valproate as a treatment for McArdle disease in sheep","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2014.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}